drugset / Trial / NCT01905631
Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus
Phase 2
Completed
30 enrolled
The Center for Clinical and Cosmetic Research
Onset Dermatologics, Inc. · collab
RandomizedSingle-groupDouble-blindTreatment
Summary
To demonstrate the ability of Aurstat to reduce pruritus in subjects with mild to moderate atopic dermatitis. Efficacy results will be based on subject assessment, IGA, and photographic evidence based on ordinal scales for tolerability.
Timeline
- Start
- 2013-07
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aurstat | Unknown | — | — |